Cipla gets USFDA nod for rare genetic condition treatment drug

The firm received final approval for its abbreviated new drug application for Icatibant Injectable 30mg/3mL from the United States Food and Drug Administration.

from The Hindu - Business https://ift.tt/30bM77b
via IFTTT

Post a Comment

0 Comments